Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
===================================================================================================================================

* Marijo Bilusic
* Christopher R. Heery
* Julie M. Collins
* Renee N. Donahue
* Claudia Palena
* Ravi A. Madan
* Fatima Karzai
* Jennifer L. Marté
* Julius Strauss
* Margaret E. Gatti-Mays
* Jeffrey Schlom
* James L. Gulley